Asthma More Common Among Youth Reporting Cannabis Use
By Lori Solomon HealthDay Reporter
WEDNESDAY, Feb. 7, 2024 -- Asthma is more common among youth who use cannabis, according to a study published online Jan. 19 in Pediatric Pulmonology.
Kevin D. Silverman, M.P.H., from the City University of New York in New York City, and colleagues investigated the relationship between frequency of cannabis use and prevalence of asthma among U.S. youth. The analysis included participants in the 2019 Youth Risk Behavior Surveillance System (grades nine to 12).
The researchers found that asthma was more common among youth who reported any cannabis use versus youth who reported no use (29.07 versus 23.62 percent; adjusted odds ratio, 1.25). Asthma prevalence was greater among youth who reported more frequent cannabis use. Among youth who reported having used cannabis ≥40 times in the month, asthma was highest (31.38 percent; adjusted odds ratio, 1.35).
"Asthma is more common among youth who use cannabis, relative to those who do not," the authors write. "More public health and clinical research is needed quickly to produce scientific data that can inform clinical guidelines and public health policy, as well as parents and youth, on the potential relationship between cannabis use and respiratory health among youth."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-02-08 00:15
Read more
- Washington Becomes 6th State to Report Bird Flu in Humans
- Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries
- Diadem Unveils Novel Findings on Early Alzheimer's Disease Detection Using p53-Specific Antibody at CTAD 2024
- FDA Approves Emrosi (minocycline hydrochloride) for the Treatment of Rosacea
- Early TAVR Beneficial for Asymptomatic Severe Aortic Stenosis
- Clinical Practice Guideline Updated for Migraine, Tension-Type Headache
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions